Protalix BioTherapeutics Inc (PLX)
1.125
-0.02
(-2.17%)
USD |
NYAM |
Apr 18, 16:00
1.125
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Shareholders Equity (Quarterly): 33.57M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.57M |
| September 30, 2023 | 38.25M |
| June 30, 2023 | 39.00M |
| March 31, 2023 | 1.008M |
| December 31, 2022 | -10.64M |
| September 30, 2022 | -11.51M |
| June 30, 2022 | -9.889M |
| March 31, 2022 | -7.486M |
| December 31, 2021 | -6.036M |
| September 30, 2021 | 0.213M |
| June 30, 2021 | 3.841M |
| March 31, 2021 | 14.50M |
| December 31, 2020 | -27.04M |
| September 30, 2020 | -33.32M |
| June 30, 2020 | -34.76M |
| March 31, 2020 | -30.88M |
| December 31, 2019 | -70.32M |
| September 30, 2019 | -70.85M |
| June 30, 2019 | -67.48M |
| March 31, 2019 | -59.86M |
| December 31, 2018 | -52.88M |
| September 30, 2018 | -64.99M |
| June 30, 2018 | -49.57M |
| March 31, 2018 | -39.44M |
| December 31, 2017 | -29.46M |
| Date | Value |
|---|---|
| September 30, 2017 | -26.07M |
| June 30, 2017 | -20.67M |
| March 31, 2017 | -68.47M |
| December 31, 2016 | -9.957M |
| September 30, 2016 | -15.10M |
| June 30, 2016 | -7.976M |
| March 31, 2016 | 2.65M |
| December 31, 2015 | 10.87M |
| September 30, 2015 | -68.51M |
| June 30, 2015 | -65.14M |
| March 31, 2015 | -61.15M |
| December 31, 2014 | -55.60M |
| September 30, 2014 | -47.69M |
| June 30, 2014 | -39.79M |
| March 31, 2014 | -33.58M |
| December 31, 2013 | -26.95M |
| September 30, 2013 | -16.71M |
| June 30, 2013 | -11.99M |
| March 31, 2013 | -6.283M |
| December 31, 2012 | -3.357M |
| September 30, 2012 | 4.772M |
| June 30, 2012 | 7.863M |
| March 31, 2012 | -6.457M |
| December 31, 2011 | -26.08M |
| September 30, 2011 | -17.35M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-70.85M
Minimum
Sep 2019
39.00M
Maximum
Jun 2023
-13.15M
Average
-9.889M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Agenus Inc | -160.33M |
| InfuSystems Holdings Inc | 52.30M |
| Corbus Pharmaceuticals Holdings Inc | -6.905M |
| AIM ImmunoTech Inc | 10.23M |
| Armata Pharmaceuticals Inc | -32.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 84.43M |
| Total Liabilities (Quarterly) | 50.86M |
| Debt to Equity Ratio | 0.6033 |
| Current Ratio | 1.536 |
| Net Debt Paydown Yield | 1.21% |